Your Health Plan:
Your Health Plan:
Not SelectedMOUNJARO (tirzepatide) is a brand-name prescription drug for treatment of Diabetes Mellitus, Non-Insulin-Dependent. MOUNJARO is a glucose-dependent insulinotropic polypeptide receptor agonist / glp-1 receptor agonist. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $900-1200.
No other option is found for MOUNJARO